Abbie Ochsner: Honored to be the inaugural NIHD DAISY Award recipient

Abbie Ochsner shared the following on LinkedIn:

’I am honored to be chosen as the inaugural Nursing Institute for Healthcare Design (NIHD) DAISY Award recipient at the HCD Healthcare Design Expo & Conference. Thank you to the NIHD leadership for pursuing the DAISY Award and making this weekend so special.

Thank you to Mahshid Jalalian, Terri Zborowsky, and the HGA team for your design research and collaboration with our St. Elizabeth Healthcare Cancer Center. Also, thank you to Kathy Jennings for your leadership and coming to support me today.

I’m excited to become a new member of NIHD as I recognize how vital it is for nurses to contribute to healthcare design. Our insights shape safer, more efficient spaces for patients and caregivers alike. I encourage fellow nurses to join NIHD and bring your voice to the table. Together, we can make a lasting impact on the future of healthcare environments!’”

Douglas Flora reposted Abbie’s post, adding the following:

“Congratulations to our own Abbie Ochsner for earning this prestigious recognition. St. Elizabeth Healthcare and Northern Kentucky friends, show Abbie some love!

Source: Abbie Ochsner/LinkedIn and Douglas Flora/LinkedIn

Abbie Ochsner is the Director of Oncology Infusion Services at St. Elizabeth Healthcare. She earned her master’s degree from the Northern Kentucky University. She was previously the director of nursing excellence at St. Elizabeth Healthcare.

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.